Results 91 to 100 of about 123 (105)

Factors Affecting Administration of Nondepolarizing Neuromuscular Blocking Agents

ASA Refresher Courses in Anesthesiology, 1980
openaire   +1 more source

The pharmacology of GW280430A: A new nondepolarizing neuromuscular blocking agent

Seminars in Anesthesia, Perioperative Medicine and Pain, 2002
openaire   +1 more source

A862 G1–64, A NEW, RAPIDLY ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT

Anesthesiology, 1990
L. Gyermek, N. Nguyen, C. Lee
openaire   +1 more source

Cisatracurium: a new nondepolarizing neuromuscular blocking agent.

Connecticut medicine, 1996
C A, Owens, J, Brakoniecki
openaire   +1 more source

AUTONOMIC/NEUROMUSCULAR DOSE-RATIOS AND HEMODYNAMIC EFFECTS OF BW785U, A SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENT

Anesthesiology, 1979
William B. Wastila, John J. Savarese
openaire   +1 more source

Are nondepolarizing neuromuscular blocking agents truly a risk factor for late-onset ventilator-associated pneumonia?

Intensive Care Medicine, 2005
Dongelmans, Dave A., Schultz, Marcus J.
openaire   +2 more sources

[Neuromuscular blockade. Dosage of nondepolarizing agents to risk-group patients].

Ugeskrift for laeger, 1995
P E, Holst, D, Ostergaard, J, Bonde
openaire   +1 more source

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Anesthesiology, 2010
openaire   +2 more sources

Onset–potency relationship of nondepolarizing muscle relaxants: a reexamination using simulations

Canadian Journal of Physiology and Pharmacology, 2007
A Amann
exaly  

Faculty Opinions recommendation of Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2016
openaire   +1 more source